Literature DB >> 29327914

Mechanistic Evaluation of Bioorthogonal Decaging with trans-Cyclooctene: The Effect of Fluorine Substituents on Aryl Azide Reactivity and Decaging from the 1,2,3-Triazoline.

Siddharth S Matikonda1, Jessica M Fairhall1, Franziska Fiedler1, Suchaya Sanhajariya1, Robert A J Tucker1, Sarah Hook1, Anna L Garden1, Allan B Gamble1.   

Abstract

Bioorthogonal prodrug activation/decaging strategies need to be selective, rapid and release the drug from the masking group upon activation. The rates of the 1,3-dipolar cycloaddition between a trans-cyclooctene (TCO) and a series of fluorine-substituted azido-PABC self-immolative spacers caging two model drugs, and subsequent release from the 1,2,3-triazoline are reported. As the number of fluorine substituents on the PABC linker increases from one to four, the rate of cycloaddition increases by almost one order of magnitude. Using a combination of fluorescence, 1H/19F NMR, and computational experiments, we have been able to determine how substituents on the PABC ring can influence the degradation rates and also the product distribution of the 1,2,3-triazoline. We have also been able to determine how these substituents influence the rate of imine hydrolysis and 1,6-self-immolation decaging rates of the generated anilines. The NMR and computational studies demonstrate that fluorine substituents on the aromatic ring lower the transition state energy required for converting the triazoline to the imine or aziridine intermediates via extrusion of diatomic nitrogen, and that in the case of a tetrafluoro substituted aromatic ring, it is the imine hydrolysis and 1,6-self-immolation that is rate-limiting. This knowledge further enhances the understanding of factors which influence the stability of triazolines, and enables potential applications of fluorinated aromatics, in particular, perfluorinated aromatics, in synthetic chemistry and sustained-release drug delivery systems.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29327914     DOI: 10.1021/acs.bioconjchem.7b00665

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  7 in total

1.  Control of Intra- versus Extracellular Bioorthogonal Catalysis Using Surface-Engineered Nanozymes.

Authors:  Riddha Das; Ryan F Landis; Gulen Yesilbag Tonga; Roberto Cao-Milán; David C Luther; Vincent M Rotello
Journal:  ACS Nano       Date:  2018-12-10       Impact factor: 15.881

2.  Selective treatment of intracellular bacterial infections using host cell-targeted bioorthogonal nanozymes.

Authors:  Joseph Hardie; Jessa Marie Makabenta; Aarohi Gupta; Rui Huang; Roberto Cao-Milán; Ritabrita Goswami; Xianzhi Zhang; Parvati Abdulpurkar; Michelle E Farkas; Vincent M Rotello
Journal:  Mater Horiz       Date:  2022-05-10       Impact factor: 15.717

3.  Development of a bioorthogonal fluorescence-based assay for assessing drug uptake and delivery in bacteria.

Authors:  Jocelyn M F Ooi; Jessica M Fairhall; Benjamin Spangler; Daniel J W Chong; Brian Y Feng; Allan B Gamble; Sarah Hook
Journal:  RSC Adv       Date:  2022-05-23       Impact factor: 4.036

4.  Polymer-Based Bioorthogonal Nanocatalysts for the Treatment of Bacterial Biofilms.

Authors:  Rui Huang; Cheng-Hsuan Li; Roberto Cao-Milán; Luke D He; Jessa Marie Makabenta; Xianzhi Zhang; Erlei Yu; Vincent M Rotello
Journal:  J Am Chem Soc       Date:  2020-06-08       Impact factor: 15.419

5.  Tetrafluoroaryl azide as an N-terminal capping group for click-to-dissolve diphenylalanine hydrogels.

Authors:  Sumit Dadhwal; Jessica M Fairhall; Sarah Hook; Allan B Gamble
Journal:  RSC Adv       Date:  2020-03-03       Impact factor: 3.361

6.  Switching on prodrugs using radiotherapy.

Authors:  Jin Geng; Yichuan Zhang; Quan Gao; Kevin Neumann; Hua Dong; Hamish Porter; Mark Potter; Hua Ren; David Argyle; Mark Bradley
Journal:  Nat Chem       Date:  2021-06-10       Impact factor: 24.427

Review 7.  Bioorthogonal Ligations and Cleavages in Chemical Biology.

Authors:  Youshan Li; Hua Fu
Journal:  ChemistryOpen       Date:  2020-08-14       Impact factor: 2.911

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.